Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Gastrointestinal Surgery
Erschienen in: Journal of Gastrointestinal Surgery 2/2020

29.08.2019 | Review Article

Clinical Utility of Autologous Salvaged Blood: a Review

verfasst von: Steven M. Frank, Robert A. Sikorski, Gerhardt Konig, Diamantis I. Tsilimigras, Jan Hartmann, Mark A. Popovsky, Timothy M. Pawlik, Jonathan H. Waters

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Autologous salvaged blood, commonly referred to as “cell saver” or “cell salvage” blood, is an important method of blood conservation. Understanding the mechanism of action and summarizing the existing evidence regarding the safety, efficiency, and the relative costs of cell salvage may help educate clinicians on how and when to best utilize autotransfusion.

Methods

This review focuses on issues concerning the quality of red blood cells (RBC), efficiency, and the cost effectiveness relative to autotransfusion. The key considerations of safe use and clinical applicability are described along with the challenges for wider dissemination.

Results

Cell salvage can reduce requirements for allogeneic transfusions, along with the associated risks and costs. Autologous salvaged RBCs provide high-quality transfusion, since the cells have not been subjected to the adverse effects of storage as occurs with banked blood. The risks for RBC alloimmunization and transfusion-related infectious diseases are also avoided. With a careful selection of cases, salvaged blood can be more cost effective than donor blood. Cell salvage may have a role in cardiac, major vascular, orthopedic, transplant, and trauma surgeries. However, there remain theoretical safety concerns in cases with bacterial contamination or in cancer surgery.

Conclusion

In addition to other methods of blood conservation used in patient blood management programs, autologous salvaged blood adds value and is cost effective for appropriate surgical cases. Evidence suggests that autologous salvaged blood may be of higher quality and confer a cost reduction compared with the allogeneic banked blood, when used appropriately.
Literatur
1.
Dodd RY. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections. British journal of haematology. 2012;159(2):135–142.PubMed
2.
Carson JL, Triulzi DJ, Ness PM. Indications for and adverse effects of red-cell transfusion. N Engl J Med. 2017;377(13):1261–1272.PubMed
3.
Sadana D, Pratzer A, Scher LJ, et al. Promoting high-value practice by reducing unnecessary transfusions with a patient blood management program. JAMA Intern Med. 2018;178(1):116–122.PubMed
4.
Halsted WS. Reinfusion in carbonic oxide poisoning. NY Med J. 1883.
5.
Wilson JD, Taswell HF. Autotransfusion: Historical review and preliminary report on a new method. Mayo Clinic proceedings. 1968;43(1):26–35.PubMed
6.
Sikorski RA, Rizkalla NA, Yang WW, Frank SM. Autologous blood salvage in the era of patient blood management. Vox sanguinis. 2017;112:499–510.PubMed
7.
Scott AV, Nagababu E, Johnson DJ, et al. 2,3-Diphosphoglycerate concentrations in autologous salvaged versus stored red blood cells and in surgical patients after transfusion. Anesth Analg. 2016;122(3):616–623.PubMedPubMedCentral
8.
Heaton A, Keegan T, Holme S. In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. British journal of haematology. 1989;71(1):131–136.PubMed
9.
Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003;29(5):435–450.PubMed
10.
Frank SM, Abazyan B, Ono M, et al. Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg. 2013;116(5):975–981.PubMedPubMedCentral
11.
Salaria ON, Barodka VM, Hogue CW, et al. Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg. 2014;118(6):1179–1187.PubMedPubMedCentral
12.
Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev. 2001;15(2):91–107.PubMed
13.
Yazer MH, Waters JH, Elkin KR, Rohrbaugh ME, Kameneva MV. A comparison of hemolysis and red cell mechanical fragility in blood collected with different cell salvage suction devices. Transfusion. 2008;48(6):1188–1191.PubMed
14.
Waters JH, Williams B, Yazer MH, Kameneva MV. Modification of suction-induced hemolysis during cell salvage. Anesth Analg. 2007;104(3):684–687.PubMed
15.
Sistino JJ, Owitz D, Mongero LB. Heparin washout in the pediatric Cell Saver bowl. The journal of extra-corporeal technology. 1992;24(3):94–96.PubMed
16.
Kling D, Borner U, von Bormann B, Hempelmann G. [Heparin elimination and free hemoglobin following cell separation and washing of autologous blood with Cell Saver 4]. Anasth Intensivther Notfallmed. 1988;23(2):88–90.PubMed
17.
Gravlee GP, Hopkins MB, Yetter CR, Buss DH. Heparin content of washed red blood cells from the cardiopulmonary bypass circuit. J Cardiothorac Vasc Anesth. 1992;6(2):140–142.PubMed
18.
Paravicini D, Schmitz-Huebner U, Stinnesbeck B. [Heparin elimination in intraoperative autotransfusion with the haemonetics cell saver]. Infusionstherapie und klinische Ernahrung. 1983;10(1):19–21.PubMed
19.
Waters JH, Lee JS, Karafa MT. A mathematical model of cell salvage efficiency. Anesth Analg. 2002;95(5):1312–1317, table of contents.
20.
Haynes SL, Bennett JR, Torella F, McCollum CN. Does washing swabs increase the efficiency of red cell recovery by cell salvage in aortic surgery? Vox sanguinis. 2005;88(4):244–248.PubMed
21.
Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. The Cochrane database of systematic reviews. 2010(4):CD001888.
22.
So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): A randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology. 2014;120(4):839–851.PubMed
23.
So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip- and knee-replacement surgery (part 2): A randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anesthesiology. 2014;120(4):852–860.PubMed
24.
van Bodegom-Vos L, Voorn VM, So-Osman C, et al. Cell salvage in hip and knee arthroplasty: A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2015;97(12):1012–1021.PubMed
25.
Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453–2462.PubMedPubMedCentral
26.
Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377(22):2133–2144.PubMed
27.
Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997–1008.PubMed
28.
Robertson CS, Hannay HJ, Yamal JM, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: A randomized clinical trial. Jama. 2014;312(1):36–47.PubMedPubMedCentral
29.
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New Engl J Med. 2013;368(1):11–21.PubMed
30.
Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381–1391.PubMed
31.
Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. Jama. 2010;304(14):1559–1567.PubMed
32.
Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–417.PubMed
33.
Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609–1619.PubMed
34.
Geoghegan J, Daniels JP, Moore PA, Thompson PJ, Khan KS, Gulmezoglu AM. Cell salvage at caesarean section: The need for an evidence-based approach. BJOG : an international journal of obstetrics and gynaecology. 2009;116(6):743–747.
35.
Fong J, Gurewitsch ED, Kang HJ, Kump L, Mack PF. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery. Anesth Analg. 2007;104(3):666–672.PubMed
36.
Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. International journal of obstetric anesthesia. 2008;17(1):37–45.PubMed
37.
Khan KS, Moore PAS, Wilson MJ, et al. Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). PLoS Med. 2017;14(12):e1002471.PubMedPubMedCentral
38.
Prick BW, Steegers EA, Jansen AJ, et al. Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy Childbirth. 2010;10:83.PubMedPubMedCentral
39.
Healy CF, Doyle M, Egan B, Hendrick B, O’Malley MK, O’Donohoe MK. Transfusion requirements and outcomes in patients undergoing abdominal aortic surgery using intra-operative cell salvage. Irish journal of medical science. 2007;176(1):33–36.PubMed
40.
Serracino-Inglott F, Awad S, Barclay A, Nasim A. The use of a cell saver during repair of ruptured abdominal aortic aneurysms increases early survival. Annals of the Royal College of Surgeons of England. 2005;87(6):475.PubMedPubMedCentral
41.
Takagi H, Sekino S, Kato T, Matsuno Y, Umemoto T. Intraoperative autotransfusion in abdominal aortic aneurysm surgery: Meta-analysis of randomized controlled trials. Archives of surgery. 2007;142(11):1098–1101.PubMed
42.
Markovic M, Davidovic L, Savic N, Sindjelic R, Ille T, Dragas M. Intraoperative cell salvage versus allogeneic transfusion during abdominal aortic surgery: Clinical and financial outcomes. Vascular. 2009;17(2):83–92.PubMed
43.
Bridgens JP, Evans CR, Dobson PM, Hamer AJ. Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study. J Bone Joint Surg Am. 2007;89(2):270–275.PubMed
44.
Shenolikar A, Wareham K, Newington D, Thomas D, Hughes J, Downes M. Cell salvage auto transfusion in total knee replacement surgery. Transfusion medicine. 1997;7(4):277–280.PubMed
45.
Huet C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg. 1999;89(4):861–869.PubMed
46.
Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: A meta-analysis of randomized trials. Anesth Analg. 2009;109(2):320–330.PubMed
47.
Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: A randomised trial. Eur J Cardiothorac Surg. 2006;30(2):271–277.PubMed
48.
Golab HD, Scohy TV, de Jong PL, Takkenberg JJ, Bogers AJ. Intraoperative cell salvage in infants undergoing elective cardiac surgery: A prospective trial. Eur J Cardiothorac Surg. 2008;34(2):354–359.PubMed
49.
Frank SM, Rothschild JA, Masear CG, et al. Optimizing preoperative blood ordering with data acquired from an anesthesia information management system. Anesthesiology. 2013;118(6):1286–1297.PubMed
50.
Frank SM, Thakkar RN, Podlasek SJ, et al. Implementing a health system-wide patient blood management program with a clinical community approach. Anesthesiology. 2017;127(5):754–764.PubMed
51.
Waters JH, Dyga RM, Waters JF, Yazer MH. The volume of returned red blood cells in a large blood salvage program: where does it all go? Transfusion. 2011;51(10):2126–2132.PubMed
52.
Frank SM. Who benefits from red blood cell salvage?--Utility and value of intraoperative autologous transfusion. Transfusion. 2011;51(10):2058–2060.PubMed
53.
Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50(4):753–765.PubMed
54.
Joseph SA, Jr., Berekashvili K, Mariller MM, et al. Blood conservation techniques in spinal deformity surgery: A retrospective review of patients refusing blood transfusion. Spine. 2008;33(21):2310–2315.PubMed
55.
Resar LM, Wick EC, Almasri TN, Dackiw EA, Ness PM, Frank SM. Bloodless medicine: Current strategies and emerging treatment paradigms. Transfusion. 2016;56(10):2637–2647.PubMed
56.
Resar LM, Frank SM. Bloodless medicine: What to do when you can’t transfuse. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2014;2014(1):553–558.
57.
Poruk KE, Valero V, 3rd, Saunders T, et al. Circulating tumor cell phenotype predicts recurrence and survival in pancreatic adenocarcinoma. Ann Surg. 2016;264(6):1073–1081.PubMedPubMedCentral
58.
Waters JH, Donnenberg AD. Blood salvage and cancer surgery: Should we do it? Transfusion. 2009;49(10):2016–2018.PubMedPubMedCentral
59.
Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia. 2008;63(12):1332–1338.PubMed
60.
Beck-Schimmer B, Romero B, Booy C, et al. Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. European journal of anaesthesiology. 2004;21(1):46–52.PubMed
61.
Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstetrics and gynecology. 1995;86(3):373–378.PubMed
62.
Nieder AM, Manoharan M, Yang Y, Soloway MS. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology. 2007;69(5):881–884.PubMed
63.
Stoffel JT, Topjian L, Libertino JA. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int. 2005;96(3):313–315.PubMed
64.
Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Annals of surgical oncology. 2014;21(7):2436–2443.PubMed
65.
Kang R, Seath BE, Huang V, Barth RJ, Jr. Impact of Autologous Blood Transfusion on Survival and Recurrence among Patients Undergoing Partial Hepatectomy for Colorectal Cancer Liver Metastases. J Am Coll Surg. 2019;228(6):902–908.PubMed
66.
Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. The Cochrane database of systematic reviews. 2006(1):CD005033.
67.
Waters JH, Yazer M, Chen YF, Kloke J. Blood salvage and cancer surgery: A meta-analysis of available studies. Transfusion. 2012;52(10):2167–2173.PubMed
68.
Waters JH, Tuohy MJ, Hobson DF, Procop G. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology. 2003;99(3):652–655.PubMed
69.
Dzik W. Use of leukodepletion filters for the removal of bacteria. Immunol Invest. 1995;24(1–2):95–115.PubMed
70.
Ozmen V, McSwain NE, Jr., Nichols RL, Smith J, Flint LM. Autotransfusion of potentially culture-positive blood (CPB) in abdominal trauma: preliminary data from a prospective study. J Trauma. 1992;32(1):36–39.PubMed
71.
Bowley DM, Barker P, Boffard KD. Intraoperative blood salvage in penetrating abdominal trauma: a randomised, controlled trial. World J Surg. 2006;30(6):1074–1080.PubMed
Metadaten
Titel
Clinical Utility of Autologous Salvaged Blood: a Review
verfasst von
Steven M. Frank
Robert A. Sikorski
Gerhardt Konig
Diamantis I. Tsilimigras
Jan Hartmann
Mark A. Popovsky
Timothy M. Pawlik
Jonathan H. Waters
Publikationsdatum
29.08.2019
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2020
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-019-04374-y

Weitere Artikel der Ausgabe 2/2020

Journal of Gastrointestinal Surgery 2/2020 Zur Ausgabe

Multimedia Article

Computational Fluid Dynamics-Based Blood Flow Assessment Facilitates Optimal Management of Portal Vein Stenosis After Liver Transplantation

Original Article

Perioperative and Postoperative Effects of Preoperative Low-Calorie Restrictive Diets on Patients Undergoing Laparoscopic Sleeve Gastrectomy

Original Article

Pattern of Relapse in Hepatic Hydatidosis: Analysis of 238 Cases in a Single Hospital

Original Article

Reduced Opioid Prescription Practices and Duration of Stay after TAP Block for Laparoscopic Appendectomy

Original Article

Repeat Hepatectomy After Major Hepatectomy for Colorectal Liver Metastases

Original Article

Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.